Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Ceska Gynekologie|March 29, 2001
[Liver function tests during administration of triphasic contraceptives containing Norgestimate]J Paseka, V Unzeitig, D Cibula, et al.Ceska Gynekologie|August 23, 2000
[Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne]D Cibula, J Paseka, V Unzeitig, et al.Ceska Gynekologie|August 23, 2000
[The factor V Leiden mutation in users of hormonal contraceptives]J Paseka, V Unzeitig, D Cibula, et al.Ceska Gynekologie|November 24, 1999
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women]J Paseka, V Unzeitig, J Horejsí, et al.Ceska Gynekologie|September 25, 2001
[Hormonal contraception and thromboembolic disease--new epidemiologic data]V UnzeitigCeska Gynekologie|May 31, 2014
[Folic acid and prevention of the neural tube defects]E Doležálková, V UnzeitigCeska Gynekologie|September 20, 2017
[Tubo-ovarian abscess in the 39th week of pregnancy (case report)]A Piegzová, V UnzeitigCeska Gynekologie|June 25, 2002
[Arterial diseases in women using combined hormonal contraceptives]M Novotná, V Unzeitig, T NovotnýCeska Gynekologie|July 26, 2003
[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy]D Cibula, V Unzeitig, J ZivnýPageof 4